DRMA Competitors & Alternatives
Compare Dermata Therapeutics Inc with similar stocks in the same industry
Biotechnology
DRMA
Main Stock$1.42
Tradestie Score
37
Market Cap
$3.50M
Analyst Upside
+181.7%
Top Competitors
242 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PRLD
Prelude Therapeutics Incorporated
|
$6.63
|
$85.47M | - | 43 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.23
|
$84.52M | - | 45 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$4.63
|
$71.69M | - | 48 | Compare |
|
ARTV
Artiva Biotherapeutics, Inc. Common Stock
|
$10.93
|
$71.32M | - | 47 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$13.66
|
$67.94M | - | 41 | Compare |
|
PALI
Palisade Bio, Inc. Common Stock
|
$2.10
|
$12.21M | 3.1 | 54 | Compare |
|
RNAZ
TransCode Therapeutics, Inc. Common Stock
|
$2.87
|
$8.85M | - | 49 | Compare |
|
ENSC
Ensysce Biosciences, Inc. Common Stock
|
$0.37
|
$7.21M | - | 34 | Compare |
|
BBLG
Bone Biologics Corp Common Stock
|
$0.63
|
$5.01M | - | 52 | Compare |
|
REVB
Revelation Biosciences, Inc. Common Stock
|
$1.09
|
$3.42M | 0.0 | 38 | Compare |
More DRMA Analysis
Data updated: Aug 22, 2026 | Industry: Biotechnology (SIC 2834)
242 stocks in this industry